Study on the relationship between selenium and cadmium in diseased human lungs

• Published in: Advances in redox research : an official journal of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe 2023-04, Vol.7, p.100065, Article 100065
• Main Authors: Smith, Matthew Ryan, Hu, Xin, Jarrell, Zachery R, He, Xiaojia, Orr, Michael, Fernandes, Jolyn, Chandler, Joshua D., Walker, Douglas I., Esper, Annette, Marts, Lucian, Neujahr, David C., Jones, Dean P., Go, Young-Mi
• Format: Article
• Language: English
• Subjects: Cadmium; Metabolic pathway; Metabolomics; Pulmonary disease; Selenium
• ISSN: 2667-1379; 2667-1379
• DOI: 10.1016/j.arres.2023.100065

•Cadmium content is greater from subjects with chronic lung diseases.•Cadmium and selenium impact common metabolic pathways with opposite associations.•Fatty acid oxidation was vital among metabolic variations associated with Cd and Se. Cadmium (Cd) is a toxic environmental metal that interacts with selenium (Se) and contributes to many lung diseases. Humans have widespread exposures to Cd through diet and cigarette smoking, and studies in rodent models show that Se can protect against Cd toxicities. We sought to identify whether an antagonistic relationship existed between Se and Cd burdens and determine whether this relationship may associate with metabolic variation within human lungs. We performed metabolomics of 31 human lungs, including 25 with end-stage lung disease due to idiopathic pulmonary fibrosis, cystic fibrosis, chronic obstructive lung disease (COPD)/emphysema and other causes, and 6 non-diseased lungs. Results showed pathway associations with Cd including amino acid, lipid and energy-related pathways. Metabolic pathways varying with Se had considerable overlap with these pathways. Hierarchical cluster analysis (HCA) of individuals according to metabolites associated with Cd showed partial separation of disease types, with COPD/emphysema in the cluster with highest Cd, and non-diseased lungs in the cluster with the lowest Cd. When compared to HCA of metabolites associated with Se, the results showed that the cluster containing COPD/emphysema had the lowest Se, and the non-diseased lungs had the highest Se. A greater number of pathway associations occurred for Cd to Se ratio than either Cd or Se alone, indicating that metabolic patterns were more dependent on Cd to Se ratio than on either alone. Network analysis of interactions of Cd and Se showed network centrality was associated with pathways linked to polyunsaturated fatty acids involved in inflammatory signaling. Overall, the data show that metabolic pathway responses in human lung vary with Cd and Se in a pattern suggesting that Se is antagonistic to Cd toxicity in humans.